Cowen Financial Products LLC 13D and 13G filings for Fulcrum Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-23 3:41 pm Sale |
2022-12-30 | 13G | Fulcrum Therapeutics, Inc. FULC |
Cowen Financial Products LLC | 1,367,759 2.615% |
-729,131 (-34.77%) |
Filing |
| 2022-03-09 09:08 am Purchase |
2022-03-04 | 13G | Fulcrum Therapeutics, Inc. FULC |
Cowen Financial Products LLC | 2,096,890 5.160% |
2,096,890 (New Position) |
Filing |